Becton Dickinson (BDX) Non-Current Debt (2009 - 2026)
Becton Dickinson's (BDX) quarterly Non-Current Debt came in at $13.5 billion in Q2 2026, down 22.93% year-over-year from $17.5 billion in Q2 2025, and down 8.13% quarter-over-quarter from $14.7 billion in Q1 2026.
Analysis
Becton Dickinson (BDX) Non-Current Debt (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Non-Current Debt for 18 consecutive years, with $13.5 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 22.93% year-over-year to $13.5 billion in Q2 2026; TTM through Jun 2026 was $13.5 billion, a 22.93% decrease from a year earlier, with the FY2025 full-year figure at $17.6 billion, down 1.78% from the prior year.
- Non-Current Debt was $13.5 billion for Q2 2026 at Becton Dickinson, down from $14.7 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $18.1 billion in Q2 2024 and troughed at $13.5 billion in Q2 2026.
- A 5-year average of $16.0 billion and a median of $16.0 billion in 2023 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt grew 23.74% in 2024 and slipped 22.93% in 2026, its largest moves.
- Over 5 years, Non-Current Debt stood at $14.3 billion in 2022, then fell by 1.22% to $14.1 billion in 2023, then grew by 23.74% to $17.4 billion in 2024, then decreased by 3.0% to $16.9 billion in 2025, then slipped by 20.13% to $13.5 billion in 2026.
- The last three Non-Current Debt figures came in at $13.5 billion (Q2 2026), $14.7 billion (Q1 2026), and $16.9 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 50.32 Bn | 49.46 Bn | 2.32 Bn | 13.51 Bn |
| 2 | Medline | 48.11 Bn | 52.93 Bn | 2.22 Bn | 12.55 Bn |
| 3 | West Pharmaceutical Services | 23.93 Bn | 23.49 Bn | 329.20 Mn | 202.90 Mn |
| 4 | Baxter International | 13.34 Bn | 11.16 Bn | 1.03 Bn | 8.62 Bn |
| 5 | Stevanato Group S.p.A | 6.21 Bn | 6.11 Bn | 100.91 Mn | 370.86 Mn |
| 6 | Acme United | 241.34 Mn | 236.30 Mn | 26.69 Mn | 22.64 Mn |
| 7 | Rockwell Medical | 31.74 Mn | 6.94 Mn | 3.24 Mn | 7.24 Mn |
| 8 | Retractable Technologies | 21.26 Mn | -18.61 Mn | 190,852.00 | 336,991.00 |
| 9 | United Health Products | 12.24 Mn | 12.21 Mn | - | 80,924.00 |
| 10 | Cuprina Holdings (Cayman) | 8.09 Mn | 4.97 Mn | - | 126,201.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.51 Bn |
| Mar 31, 2026 | 14.71 Bn |
| Dec 31, 2025 | 16.92 Bn |
| Sep 30, 2025 | 17.62 Bn |
| Jun 30, 2025 | 17.53 Bn |
| Mar 31, 2025 | 17.67 Bn |
| Dec 31, 2024 | 17.44 Bn |
| Sep 30, 2024 | 17.94 Bn |
| Jun 30, 2024 | 18.13 Bn |
| Mar 31, 2024 | 16.00 Bn |
| Dec 31, 2023 | 14.09 Bn |
| Sep 30, 2023 | 14.74 Bn |
| Jun 30, 2023 | 14.93 Bn |
| Mar 31, 2023 | 16.01 Bn |
| Dec 31, 2022 | 14.27 Bn |
| Sep 30, 2022 | 13.89 Bn |
| Jun 30, 2022 | 14.68 Bn |
| Mar 31, 2022 | 17.58 Bn |
| Dec 31, 2021 | 16.36 Bn |
| Sep 30, 2021 | 17.11 Bn |